Avivagen Inc. (AVIVAGEN INC) aksje

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia, and Malaysia. The company is headquartered in Ottawa, Canada.